Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

FDA approves boceprevir, the first new hepatitis C drug in 20 yearsLos Angeles TimesThe Food and Drug Administration on Friday approved marketing of the Merck drug boceprevir, the first new drug for hepatitis C in 20 years. The agency is still considering approval of a similar drug, telaprevir, and is expected to approve it soon as ...See all stories on this topic »

Los Angeles Times

Peginterferon in Hepatitis C Linked to Higher MortalityDoctors LoungeLong-term peginterferon treatment in patients with advanced chronic hepatitis C is associated with higher overall mortality mainly due to non-liver-related causes, according to a study published in the April issue of Hepatology. ...See all stories on this topic »

FDA Grants Merck Approval to Launch Hepatitis C DrugMyFox Houston(NewsCore) - Merck & Co. won US regulatory approval to launch a new hepatitis C drug on Friday after the Food and Drug Administration approved its safety and effectiveness in clinical trials. Vicrelis was approved to treat some adults with chronic ...See all stories on this topic »

FDA Approves Merck's VICTRELIS™ (boceprevir), First-in-Class Oral Hepatitis C ...Insurance News Net (press release)VICTRELIS is the first in a new class of medicines known as hepatitis C virus (HCV) protease inhibitors approved for use in combination with peginterferon alfa and ribavirin, which is the current standard therapy, for the treatment of chronic hepatitis ...See all stories on this topic »

Patients Show Reduced Depression Rates After LocteronDrug Discovery & DevelopmentBiolex Therapeutics announced results demonstrating reduced rates of depression from its SELECT-2 Phase 2b trial of Locteron for hepatitis C treatment at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL). ...See all stories on this topic »

Telaprevir Improved Outcomes for Hep C Patients Who Failed Prior TherapyInternal Medicine News Digital NetworkCHICAGO – Adding the protease inhibitor telaprevir to the standard combination therapy of pegylated interferon alfa-2a and ribavirin significantly improved outcomes in three categories of genotype 1 hepatitis C patients who had failed standard

....See all stories on this topic »

Get the right number after exposureRDHExposure incidents might place dental health-care personnel at risk for hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) infection, and therefore should be evaluated immediately following treatment of the exposure ...See all stories on this topic »

US HOT STOCKS: Merck Shares Active In Late TradingWall Street Journal(MRK) won US regulatory approval to launch a new hepatitis C drug after the Food and Drug Administration evaluated the safety and effectiveness of the treatment in two phase-3 clinical trials. Shares climbed 1% at $37.46 in recent after-hours trading. ...See all stories on this topic »

FDA clears first new hepatitis C drug in 20 yearsHouston ChronicleAbout 3.2 million people in the US have Hepatitis C, a blood-borne disease linked to 12000 deaths a year. The current two-drug treatment for the virus cures only about 40 percent of people and causes side effects like nausea, fatigue and vomiting. ...See all stories on this topic »

HHS Launches Action Plan to Target HepatitisMedPage TodayGoals of the initiative by 2020 include increasing the percentage of patients infected with hepatitis B who are aware of their disease status from one-third to two-thirds, increasing the percentage for hepatitis C from 45% to 66%, decreasing the number ...See all stories on this topic »